Meta-analysis of NFKB1 -94 ATTG ins/del polymorphism and risk of breast cancer.

CONCLUSION: To summarize, our meta-analysis demonstrates that the NFKB1 -94 ATTG I/D polymorphism is not a major risk factor for BC.
PMID: 32156231 [PubMed - as supplied by publisher]

Source: Current Drug Metabolism - March 9, 2020 Category: Drugs & Pharmacology Authors: Kancharla J, Devi VPI, Lakkakula BV, Veera BP, Afroz A Tags: Curr Drug Metab Source Type: research